期刊文献+

血红素氧合酶-1对预防动脉粥样硬化及炎症的影响 被引量:2

Effect of Heme Oxygenase-1 on Atherosclerosis in Rats
下载PDF
导出
摘要 目的:探讨血红素氧合酶-1(HO-1)抑制动脉粥样硬化进程的机制。方法:30只雄性SD大鼠随机分为正常对照组、模型组及氯血红素组。3月后观察主动脉形态学变化,ELISA法测定血中C-反应蛋白(CRP)及白介素-6(IL-6)水平,免疫组化法检测斑块内HO-1及巨噬细胞CD68的表达。结果:模型组及氯血红素组与对照组比较,CRPI、L-6、HO-1及CD68升高(P<0.05)。氯血红素组与模型组比较,主动脉内膜斑块面积占内膜面积比(RAAPI)显著减少(P<0.01),HO-1升高(P<0.01),CRPI、L-6及CD68降低(P<0.05)。结论:HO-1对动脉粥样硬化有明显的预防作用,这种作用可能是通过抑制炎症因子及巨噬细胞数量,减少炎症反应来实现的。 Objective: To explore the inhibition mechanism of heme oxygenase-1 (HO-1) on the progress of atherosclerosis in rats. Methods: Thirty male SD rats were randomly divided into three groups as control group, model group and hemin group. After three months, the serum concentrations of C-reaction protein(CRP) and interleulin-6(IL-6) of each group were measured. The expression of HO-1 and CD68 was measured by immunenhistochemistry. Results: Compared with that respectively in the control group, the CRP, IL-6, HO-1 and CD-68 in the model group and the hemin group increased significantly (P〈0.05). Compared with that in the model group, HO-1 of the hemin group increased significantly (P〈0.01), while the RAAPI, MDA, CD68 and MMP-9 decreased (P〈0. 05). Conclusion: Heme oxygenase-1 can prevent atherosclerotic progression through inhibiting the inflammatory factors and decreasing the macrophages number, accordingly inhibiting the inflammatory response.
出处 《武汉大学学报(医学版)》 CAS 2007年第2期216-218,F0002,共4页 Medical Journal of Wuhan University
关键词 病理生理学 血红素氧合酶-1 动脉粥样硬化 炎症 Pathophysiology Heme Oxygenase-1 Atherosclerosis Inflammation
  • 相关文献

参考文献10

  • 1Jakab L.The pathogenesis of atherosclerosis[J].OrvHetil,2003,144(23):1 121-1 128.
  • 2Ishikawa K,Sugawara D,Wang XP,et al.Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice[J].Circ Res,2001,88:506-512.
  • 3Juan SH,Lee TS,Tseng KW,et al.Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice[J].Arterioscler Thromb Vasc Biol,2001,21(8):1 373-1 377.
  • 4Nakayama M,Takahashi K,Komaru T,et al.Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions[J].Arterioscler Thromb Vasc Biol,2001,21:1 373-1 377.
  • 5Otterbein LE,Bach FH,Alam J,et al.Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway[J].Nat Med,2000,6(4):422-428.
  • 6Davis NE.Atherosclerosis-an inflammatory process[J].J Insur Med,2005,37(1):72-75.
  • 7Boyle JJ.Macrophage activation in atherosclerosis:pathogenesis and pharmacology of plaque rupture[J].Curr Vasc Pharmacol,2005,3(1):63-68.
  • 8Lutgens E,Suylen RJ,Faber BC,et al.Atherosclerotic plaque rupture:local or systemic process[J]? Arterioscler Thromb Vasc Biol,2003,23(12):2 123-2 130.
  • 9Wilson AM,Ryan MC,Boyle AJ.The novel role of C-reactive protein in cardiovascular disease:risk marker or pathogen[J].Int J Cardiol,2006,106(3):291-297.
  • 10梁春,吴宗贵.急性冠状动脉综合征血清学标志物研究进展[J].中华老年心脑血管病杂志,2001,3(5):350-353. 被引量:6

二级参考文献16

  • 1Kai H,Jkeda H,Yasukwa H,et al.Peripheral blood levels of matrix metalloproteinases-2 and-9 are elevated in patients with acute coronary syndromes[J].J Am Coll Cardiol,1998,32:368-372
  • 2Ueda H,Imazu M,Hayashi Y,et al.Immunohistochemical analysis of hepatocyte growth factor in human coronary atherectomy specimens:comparison with transforming growth factor beta isoforms[J].Virchows Arch,1997,430:407-415
  • 3Sato T,Yoshinouchi T,sugimoto T,et al.Prognostic value of serum hepatocyte growth factor in patients with acute coronary syndromes[J].Jpn Circ J,1999,63:583-588
  • 4Xu Q,Kiechl S,Mayr M,et al.Association of serum antibodies to heatshock protein 65 with carotid atherosclerosis:clinical significance determined in a follow-un study[see comments][J].Circulation,1999,100:1169-1174
  • 5Gawaz M,Reininger A,Neumann FJ,Platelet function and pletelet-leukocyte adhesion in symptomatic coronary disease.Effects of intravenous magnesium[J].Throm Res,1996,83:341-349
  • 6Carvili DGM,Dimitrijeric N,Walsh M,et al.Thrombus precursor protein:marker of thrombosis early in the pathogenesis of myocardial infarction[J].Clin Chem,1996,42:1537-1541
  • 7Lee L,Ewald GA,Mckenzie CR,et al.The relationship of soluble fibrin and cross-linked fibrin degradation products to the clinical course of myocardial infarction[J].Arterioscler Thromb Vasc Biol,1997,17:628-633
  • 8Zhang YX,Cliff WJ,WSchoefl GI,et al.Coronary C-reactive protein distribution:is relation to deverlopment of atheroslerosis[J].Atherosclerosis,1999,145:375-379
  • 9Lagrand WK,Visser CA,Hermens WT,et al.C-reactive protein as a cardiovascular risk factor:more than an epiphenomenon?[J].Circulation,1999,100:96-102
  • 10Maresca G,Di Blasio A,Marchioli R,et al.Measuring plasma fibrinogen to predict stroke and myocardial infarction:an update[J].Arterioscler Thromb Vasc Biol,1999,19:1368-1377

共引文献5

同被引文献33

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部